{ "model": "qwen/qwen3.6-35b-a3b", "started_at": "2026-05-16T19:24:20.666Z", "system_prompt": "You are Analyst, the thesis-judgment stage of an AI trade-ideas pipeline.\n\nScout has already gathered a JSON dossier of scoring_inputs. Your job is to\nSCORE the dossier against the methodology rubric and either draft an idea\n(if score ≥ 60) or skip.\n\nOPTION B (skip) IS THE EXPECTED DEFAULT. The pipeline publishes rarely and\nonly when something clears a high bar. Most dossiers should return\n{ \"skip\": true, \"reason\": \"...\", \"score\": }. Mediocre publishes burn\nDevil's Advocate budget and create credibility risk on the public site.\n\nLOOK AT THE FULL STRUCTURE MENU. Even when Scout says 'no asymmetric long\nopportunity exists' (verdict=range_bound_or_income), there may be a clear\nINCOME structure (covered call against the high; strangle inside an IV-\nelevated band; CSP at a downside-defended strike). Don't reflex-skip just\nbecause long_stock isn't attractive. Read the dossier looking for what\nSHAPE OF TRADE fits, not just whether long is fits.\n\nSCORING RUBRIC (sum to max 100)\n\nA. SMART-MONEY CLUSTER (max 25) — from scoring_inputs.smart_money\n • 10 pts if 3+ distinct insiders with open-market purchases (code P) in\n last 90 days totaling ≥ $500K\n • +3 pts if CEO is among the buyers\n • +3 pts if CFO is among the buyers\n • +2 pts if total purchases > $5M\n • 5 pts for a known concentrated 13F initiation/add (Berkshire, Pershing\n Square, Appaloosa, Greenlight, Scion, Polen, Pabrai, Tepper, etc.)\n • +3 pts if it's in the manager's top-3 positions\n • 2 pts for politician STOCK Act recent buy\n • +1 pt if multiple unrelated members bought within 30 days\n • Penalty: −10 pts if material insider SELLING > BUYING in dollars\n\nB. OPTIONS FLOW / UOA (max 10) — from scoring_inputs.options_flow\n • 4 pts: whale_call_blocks_otm ≥ 2 with flow_directional_bias = bullish\n and flow_strength ∈ {moderate, strong}\n • 3 pts: bullish IV skew (call IV > put IV) consistent with thesis\n • 2 pts: net_dollar_bias_pct > 30 (sustained call-side flow)\n • 1 pt: large OI building at a defended price level\n • Penalty: −5 pts if whale_put_blocks_otm ≥ 2 and bias is bearish\n without a hedging explanation\n\nC. CATALYST (max 25) — from scoring_inputs.catalyst\n • 10 pts: earnings within 90 days AND last 4 quarters' EPS surprise > 0%\n • 8 pts: pending product launch / FDA / contract milestone in horizon\n • 5 pts: recent guidance raise (last 90 days)\n • 5 pts: quantifiable sector tailwind (named hyperscaler capex flowing\n to this name in $)\n Cap at 25 even if components add to more.\n\nD. MISPRICING (max 15) — from scoring_inputs.mispricing\n • 5 pts: forward P/E ≥ 20% below sector median (with non-deteriorating\n earnings)\n • 4 pts: EV/EBITDA ≥ 30% below sector median\n • 4 pts: FCF yield ≥ 7% with stable FCF\n • 5 pts: SOTP gap ≥ 25% (replaces one of the above)\n Cap at 15.\n\nE. QUALITY (max 15) — from scoring_inputs.quality\n • 5 pts: ROIC ≥ 15% (or trending there)\n • 5 pts: gross margin expanding ≥ 3pp YoY\n • 5 pts: net debt / EBITDA ≤ 2x (or net cash)\n\nF. MOMENTUM/TECHNICAL (max 10) — from scoring_inputs.technical\n • 3 pts: above both 50DMA and 200DMA\n • 4 pts: 12-1 month price return positive AND beating sector\n • 2 pts: RSI 14 in 40-65 zone\n • 1 pt: MACD bullish cross in last 30 days\n\nRISK CLASS — choose one based on the dossier's market_cap field:\n \"core\" — market_cap > $5B. Standard methodology sizing.\n \"asymmetric\" — market_cap ≤ $5B (small-cap moonshot). 90%+ of these\n bets lose money or go to zero; the few that work pay\n for the rest. Position sizing is far more conservative\n to fit the variance.\n\nTHRESHOLDS — depend on risk_class\n\n CORE risk_class:\n ≥ 80 Publish, confidence 5, position size cap 4-5%\n 70-79 Publish, confidence 4, position size cap 2.5-3.0%\n 60-69 Publish, confidence 3, position size cap 1.5-2.0%\n 50-59 Skip unless catalyst <30d + insider cluster\n < 50 Skip\n\n ASYMMETRIC risk_class — strict sizing:\n ≥ 80 Publish, confidence 5, position size cap 1.5%\n 70-79 Publish, confidence 4, position size cap 1.0%\n 60-69 Publish, confidence 3, position size cap 0.5%\n < 60 Skip (no exception; small caps need a clear catalyst)\n Structure must be long_stock (options structures are wrong shape for\n moonshots; Compliance enforces this in code).\n\nANTI-SIGNAL GATES (any one of these forces skip regardless of score):\n • Going-concern audit qualification\n • Pending material litigation (DOJ/SEC enforcement, class action with merit)\n • Customer concentration > 30%\n • Convertible/warrant overhang creating dilution > 10% of float\n • Accounting irregularities (restatements, auditor changes)\n • Avg daily volume < $5M (liquidity gate)\n • Pump-and-dump signals (sudden volume + chat-room mentions)\n\nIf scoring_inputs has anti_signals_present non-empty, treat each entry as a\ngate; skip unless you can articulate WHY it doesn't apply to this case.\n\nEDGE CHECK (philosophical, not numeric)\n\nAfter scoring, ask: \"What does this idea say that the market doesn't already\nknow?\" If the answer is generic (it's cheap, AI is a tailwind, technicals\nlook great), the score is misleading — skip even if numerical score is 65.\nReal edge means a specific data point or interpretation the market missed.\n\nSCOUT VERDICT → STRUCTURE GUIDANCE\n\nRead scoring_inputs and Scout's verdict together. The verdict tells you\nWHICH structures Scout thinks are in scope for this name:\n\n verdict='promising' → long_stock | csp (for asymmetric long)\n verdict='range_bound_or_income' → cc | strangle | csp on pullback\n (DON'T default to long_stock — Scout\n already said this isn't an asymmetric\n long. Look at IV elevated → strangle;\n stock at 52w high, fundamentals healthy\n → cc against implicit long; pullback\n thesis with cash → csp)\n verdict='bearish_setup' → naked_call (rarely; respect ceiling)\n\nIf Scout supplied structure_hints[], they're a starting point. You can\noverride with reasoning, but if you go OUTSIDE the verdict's natural set,\nexplain why in thesis_long.\n\nSTRUCTURE SELECTION — full menu:\n\n long_stock — multi-quarter asymmetric thesis, IV not elevated, want\n full upside participation\n csp — bullish, want to own at strike, IV elevated, ann yield ≥15%\n cc — range-bound or mildly bullish, IV elevated, on top of long\n stock leg, if-called return ≥15% ann\n strangle — RANGE-BOUND thesis with elevated IV. Sell OTM call + OTM\n put. Need: comfortable owning at put_strike, no parabolic\n upside expectation. Ann yield ≥12%. Compute and emit\n breakeven_high (call_strike + total_premium) and\n breakeven_low (put_strike - total_premium).\n naked_put — same setup as CSP but using margin. ~2x yield, margin call\n risk. Only for margin-equipped accounts. Note explicitly.\n naked_call — bearish setup with elevated IV. UNCAPPED loss if rally.\n Confidence ceiling 4 (Compliance enforces). Requires\n explicit upside-shock thesis + defense plan in conditions.\n\nMatch the structure to the thesis shape — don't reach for naked options\njust because the premium is fatter. Most candidates are best as long_stock\nor CSP. Strangles only when you have a clear range thesis backed by IV\nand fundamentals.\n\nIF YOU SKIP — output exactly:\n {\n \"skip\": true,\n \"score\": <0-100 composite>,\n \"score_breakdown\": {\n \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n },\n \"reason\": \"1-2 sentences why this dossier doesn't support a thesis.\"\n }\n\nIF YOU PROCEED — output a draft idea matching this schema (this is the same\nschema the published site renders from):\n\n{\n \"skip\": false,\n \"score\": <0-100 composite>,\n \"score_breakdown\": {\n \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n },\n \"draft\": {\n \"slug\": \"YYYY-MM-DD-symbol-keyphrase\",\n \"symbol\": \"TICKER\",\n \"company\": \"Full name\",\n \"sector\": \"semis-ai-infra\" | \"small-cap-asymmetric\",\n \"risk_class\": \"core\" | \"asymmetric\",\n \"headline\": \"Punchy 1-line — the news angle on the thesis\",\n \"thesis_short\": \"1 sentence — why this trade exists.\",\n \"thesis_long\": [\n \"Opening paragraph framing the setup.\",\n \"## Catalyst\",\n \"Detailed catalyst narrative.\",\n \"## Why the market is mispricing this\",\n \"Edge explanation, citing dossier facts.\",\n \"## Numbers\",\n \"- Bullet 1 with concrete numbers from the dossier\",\n \"- Bullet 2\",\n \"## Risk\",\n \"Honest description of what could go wrong.\"\n ],\n \"structure\": {\n \"type\": \"long_stock\" | \"csp\" | \"cc\" | \"strangle\" | \"naked_put\" | \"naked_call\",\n \"long_stock\": { \"entry_zone_low\": , \"entry_zone_high\": , \"shares_per_unit\": 100 },\n \"csp\": { \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"annualized_yield_pct\": , \"if_assigned_basis\": },\n \"cc\": { \"underlying_basis\": , \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"if_called_return_pct\": },\n \"strangle\": { \"call_strike\": , \"put_strike\": , \"expiry\": \"YYYY-MM-DD\", \"call_premium_target\": , \"put_premium_target\": , \"total_premium_target\": , \"breakeven_high\": , \"breakeven_low\": , \"annualized_yield_pct\": , \"max_loss_note\": \"...\" },\n \"naked_put\": { \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"annualized_yield_pct\": , \"max_loss_per_contract\": , \"margin_estimate_per_contract\": , \"warning\": \"...\" },\n \"naked_call\": { \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"annualized_yield_pct\": , \"max_loss\": \"UNLIMITED\", \"warning\": \"...\" }\n },\n \"entry\": {\n \"price_at_idea\": ,\n \"conditions\": \"How/when to enter — e.g., 'Open starter on pullback to MA50.'\"\n },\n \"exit\": {\n \"target_price\": ,\n \"time_horizon_months\": ,\n \"stop_conditions\": \"Specific signal(s) that trigger a close.\"\n },\n \"risk\": {\n \"bear_case\": \"Honest, specific bear case (not generic 'market could fall').\",\n \"what_breaks_thesis\": \"Specific event/data that invalidates the call.\",\n \"position_size_pct\": <0.5 to 5.0, conviction-weighted>\n },\n \"sources\": [\n { \"label\": \"...\", \"url\": \"...\" }\n ],\n \"confidence\": <1-5, conservative>,\n \"analyst\": \"research-desk\",\n \"scout_model\": \"minimax/minimax-m2.7\",\n \"analyst_model\": \"qwen/qwen3.6-35b-a3b\",\n \"devils_advocate_verdict\": null\n }\n}\n\nONLY ONE STRUCTURE TYPE. Pick long_stock, csp, OR cc and only fill that\nsub-object. Leave the others null/omitted.\n\nALL NUMBERS must be drawn from the dossier or computable from it. Do not\ninvent prices, strikes, premiums.\n\nOUTPUT ONLY VALID JSON. No surrounding prose, no markdown fences.", "user_prompt": "Here is the dossier from Scout. Decide: skip or draft.\n\n\nLESSONS LEARNED: none yet.\n\nDOSSIER:\n{\n \"symbol\": \"LEU\",\n \"company\": \"Centrus Energy Corp.\",\n \"investigation_summary\": \"Centrus Energy is the only U.S. company actively enriching HALEU (5-20% assay) under DOE contract, uniquely positioned in U.S. nuclear fuel supply chain with $3.8B backlog extending to 2040 and a January 2026 selection for a ~$900M commercial HALEU task order from DOE. However the stock has collapsed roughly 60% from its October 2025 peak (~$464 intraday) to $183, driven by three consecutive EPS misses (Q3/Q4 2025 both missed by ~50%, though Q1 2026 beat dramatically at +289% vs. consensus), elevated capex for Oak Ridge centrifuge manufacturing and Piketon expansion, and geopolitical uncertainty around Russian uranium trade policy. The balance sheet is strong ($1.9B cash vs $1.2B long-term debt) but near-term earnings are volatile given the company's contractor nature — revenues swing with DOE reimbursement timing. No open-market insider purchases were found in 90-day window; CFO sold shares in May 2026 (surrender for taxes on RSUs, not directional). Options flow shows heavy put bias (P/C ratio 1.78) and a new $130P with V/OI=9.2 — speculative bearish positioning but typical for high-volatility micro-cap. The thesis is long-term promising given nuclear renaissance tailwinds (AI power demand, advanced reactors, domestic security policy), but the stock is too early-cycle and uncertain to warrant an asymmetric long at current valuation (46x forward P/E, 85x EV/EBITDA) with negative operating margins on expanding capex.\",\n \"verdict\": \"range_bound_or_income\",\n \"confidence_in_data\": 4,\n \"structure_hints\": [\n \"csp\",\n \"cc\"\n ],\n \"business_snapshot\": \"Centrus Energy Corp. is a Bethesda-based nuclear fuel supplier that operates two segments: LEU (Low-Enriched Uranium), which provides SWU and uranium to commercial utilities globally, and Technical Solutions, which enriches HALEU for advanced reactors under DOE contracts. Centrus holds the only active NRC license to produce HALEU at 20% U-235 assay and is operating a demonstration cascade in Piketon, Ohio producing ~900 kg/year. The company was selected in January 2026 for a $900M+ DOE task order to deploy commercial-scale HALEU enrichment capacity, with additional options up to $170M for production/delivery. Separately, Congress has appropriated ~$3.4B to DOE for domestic nuclear fuel production (LEU + HALEU), and Centrus is one of three awardees under three separate IDIQ contracts totaling ~$2B in potential value. The company began manufacturing its own centrifuges at Oak Ridge in late 2024, plans >$560M investment there over several years, and initiated a 150,000 sq ft training/ops facility in Piketon in December 2025 — all while managing $3.8B in backlog (primarily contingent on securing financing for capacity expansion).\",\n \"scoring_inputs\": {\n \"smart_money\": {\n \"insider_open_market_purchases_90d\": [],\n \"insider_open_market_total_usd_90d\": 0,\n \"distinct_insider_buyers_90d\": 0,\n \"ceo_buy_present\": false,\n \"cfo_buy_present\": false,\n \"material_insider_selling_90d_usd\": 62286,\n \"notable_13f_holders\": [\n \"pending — v2\"\n ],\n \"politician_recent_buys\": [\n \"pending — v2\"\n ]\n },\n \"catalyst\": {\n \"next_earnings_date\": \"2026-08-04\",\n \"recent_eps_surprise_pattern\": \"Mixed: Q1 2026 +289% beat ($1.05 actual vs $0.27 est), but Q3 and Q4 2025 both missed by ~50%. Pattern suggests contractor-reimbursement timing volatility, not structural earnings weakness.\",\n \"guidance_raise_in_last_90d\": true,\n \"named_catalysts\": [\n {\n \"type\": \"regulatory\",\n \"description\": \"Russian Uranium Import Ban Act (enacted May 13, 2024; effective Aug 11, 2024) bans Russian LEU imports into U.S. Centrus is one of very few domestic alternatives — supply disruption creates pricing tailwind.\",\n \"date_or_window\": \"Effective August 2024, ongoing\",\n \"source_urls\": [\n \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026007117/leu-20251231.htm\"\n ],\n \"directional_bias\": \"bullish\"\n },\n {\n \"type\": \"government_contract\",\n \"description\": \"DOE selected ACO (Centrus subsidiary) for $900M+ HALEU enrichment task order to expand Piketon facility, announced January 5, 2026. Subject to final contract negotiation.\",\n \"date_or_window\": \"January 5, 2026 announcement; contract finalization pending\",\n \"source_urls\": [\n \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026030891/leu-20260331.htm\"\n ],\n \"directional_bias\": \"bullish\"\n },\n {\n \"type\": \"government_contract\",\n \"description\": \"$62.4M §48C clean-energy manufacturing tax credit allocated by IRS January 10, 2025 for Oak Ridge centrifuge manufacturing facility ($208M qualified investment).\",\n \"date_or_window\": \"January 10, 2025 allocation; 2-year placement deadline\",\n \"source_urls\": [\n \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026007117/leu-20251231.htm\"\n ],\n \"directional_bias\": \"bullish\"\n },\n {\n \"type\": \"m&a\",\n \"description\": \"EPC contract signed February 2026 with Fluor Federal Services for commercial LEU and HALEU expansion at Piketon. $60M groundwork investment initiated.\",\n \"date_or_window\": \"February 2026\",\n \"source_urls\": [\n \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026030891/leu-20260331.htm\"\n ],\n \"directional_bias\": \"bullish\"\n }\n ]\n },\n \"mispricing\": {\n \"forward_pe\": 45.99,\n \"sector_median_forward_pe\": null,\n \"ev_to_ebitda\": 84.87,\n \"sector_median_ev_to_ebitda\": null,\n \"fcf_yield_pct\": -0.3,\n \"narrative\": \"At 46x forward P/E and ~85x EV/EBITDA, LEU appears richly valued on near-term earnings given negative operating cash flow (-$35M in Q1 2026) driven by heavy capex. However, the market may be discounting a future earnings power that current government contract structures (cost-plus basis) do not immediately deliver. The $3.8B backlog provides revenue visibility but most is contingent on capital deployment — if Centrus successfully scales enrichment capacity and converts even part of its ~$2.1B in definitive contingent LEU contracts to realized sales, forward earnings estimates would shift dramatically.\"\n },\n \"quality\": {\n \"roic_pct\": null,\n \"gross_margin_trend_pp_yoy\": null,\n \"net_debt_to_ebitda\": null,\n \"balance_sheet_grade\": \"A\"\n },\n \"technical\": {\n \"above_50dma\": false,\n \"above_200dma\": false,\n \"rsi_14\": 41.9,\n \"macd_recent_bullish_cross\": false,\n \"12_1_momentum_vs_sector_pct\": null\n }\n },\n \"price_context\": {\n \"last_close\": 182.6,\n \"ytd_return_pct\": -59,\n \"from_52w_high_pct\": 60.7\n },\n \"filings_reviewed\": [\n {\n \"form\": \"10-K\",\n \"filed\": \"2026-02-11\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026007117/leu-20251231.htm\",\n \"key_takeaways\": [\n \"FY2025 revenue ~$452M; LEU segment 77% of total; backlog $3.8B extending to 2040 with $2.3B contingent on capacity expansion financing\",\n \"HALEU Operation Contract funded up to $317M aggregate through Phase 1, Phase 2, Option 1a; DOE exercised Option 1a at $108.2M through June 2026\",\n \"$62.4M §48C tax credit allocation for Oak Ridge manufacturing facility (eligible property $208M)\",\n \"Russian Import Ban Act effective Aug 11, 2024 creates domestic supply opportunity; Russian Decree extended through Dec 31, 2027\",\n \"0% Convertible Notes ($805M face, due 2032) and 2.25% Convertibles ($402.5M face, due 2030); $1.87B cash at year-end 2025\",\n \"Centrus announced major Piketon expansion Sept 2025; initiated 150K sq ft training facility design Dec 2025; began domestic centrifuge manufacturing Dec 2025\",\n \"TENEX Supply Contract extends through 2028 for SWU supply\"\n ]\n },\n {\n \"form\": \"10-Q\",\n \"filed\": \"2026-05-06\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026030891/leu-20260331.htm\",\n \"key_takeaways\": [\n \"Q1 2026 revenue $76.7M (+4.9% YoY); GAAP EPS $0.45 (diluted), +289% vs consensus $0.27; adjusted EPS $1.05\",\n \"Cash $1,868M at Q1 end; long-term debt $1,176M; operating cash flow -$35M due to capex ($23.2M) and working capital build\",\n \"Advanced technology costs spiked to $18.9M vs $3.0M in Q1 2025 — reflects Oak Ridge centrifuge manufacturing ramp-up\",\n \"HALEU Operation Contract Phase 2 delivered 900kg UF6; DOE obligated up to $317M cumulative; ACO received $247.8M cash payments through March 31, 2026\",\n \"Remaining performance obligations: LEU segment ~$0.7B (extends to 2030); Technical Solutions ~$48.1M (through 2026)\",\n \"EPC contract signed February 2026 with Fluor Federal Services for Piketon expansion; financial assurance escrow $30.1M established\",\n \"Russian Decree effective through Dec 31, 2027 limits Russian LEU exports to U.S.; Import Ban Act bans imports\"\n ]\n }\n ],\n \"options_context\": {\n \"expiries_examined\": [\n \"2026-06-18\",\n \"2026-10-16\"\n ],\n \"iv_summary\": \"ATM IV ~82-87% across near and mid-term expiries. Elevated for a micro-cap energy name, supporting income premium.\",\n \"notable_skew_or_flow\": \"P/C volume ratio 1.78 with -$1.43M net dollar bias toward puts. Notable: 405-lot $130P showing V/OI=9.2 (new positioning, not turnover). Top OI on calls: $250 (858), $300 (641); top OI on puts: $150 (834), $160 (476), $200 (404). Put skew suggests hedging or speculative bearish bets from option market makers rather than directional smart-money. 180P ATM has IV ~82% — high premium available.\"\n },\n \"competitive_landscape\": \"Centrus is the only U.S.-origin uranium enrichment company with active operations and an NRC license for HALEU up to 20% assay. Global competitors (Orano, URENCO, Rosatom/TENEX) are foreign-state-owned or subject to import bans. No domestic LEU/HALEU competitor exists at scale in the U.S. — Centrus is a near-monopoly on domestic production capability, making its strategic value potentially enormous but execution-dependent.\",\n \"key_risks\": [\n \"Government funding concentration risk: ~50% of Q1 2026 revenue from DOE contracts; if Congressional appropriations for nuclear fuel programs are cut, company loses primary growth engine\",\n \"Geopolitical exposure to Russia/Ukraine resolution: Russian Decree and TENEX Supply Contract both extend through 2028 — diplomatic normalization could eliminate the supply disruption premium embedded in market prices\",\n \"Capital deployment execution risk: Company plans $560M+ Oak Ridge investment + Piketon expansion with minimal near-term revenue offset; cost overruns could erode cash faster than projected\",\n \"Dilution from convertible conversions: $1.2B face value convertibles at current stock levels are far OTM, but any equity raise would be dilutive given ~19M share count\",\n \"TENEX supply contract dependency: Until domestic LEU capacity is built, Centrus remains dependent on Russian-origin SWU for a significant portion of commercial sales — any disruption in payment mechanisms could strand inventory\",\n \"Earnings volatility from contractor reimbursement timing: Quarterly results swing dramatically based on DOE billing cycle, not underlying business health; complicates fundamental analysis\"\n ],\n \"what_the_market_might_be_missing\": \"The October 2025 stock peak (~$464) appears to have priced in near-term success of the $900M HALEU task order and full LEU capacity expansion — but contract finalization delays and cost overrun concerns caused a ~60% drawdown. The market may be underpricing the strategic moat that Centrus has built as the sole U.S.-origin enrichment licensee with NRC approval: in a world where AI data centers require reliable nuclear baseload power, and where Congress has appropriated $3.4B specifically to revive domestic uranium enrichment capability for national security reasons, this monopoly position on domestic HALEU production could command significant pricing power once capacity is online. The stock at ~$183 (vs. 52w high of $464) trades at levels that reflect near-term uncertainty rather than the multi-decade backlog value.\",\n \"anti_signals_present\": [\n \"dilution\",\n \"concentration\"\n ],\n \"sources\": [\n {\n \"label\": \"10-K FY2025\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026007117/leu-20251231.htm\"\n },\n {\n \"label\": \"10-Q Q1 2026\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026030891/leu-20260331.htm\"\n },\n {\n \"label\": \"Form 4 — CFO Tinelli May 2026 sale\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/1065059/000162828026033509/xslF345X06/wk-form4_1778530670.xml\"\n },\n {\n \"label\": \"Form 4 — CFO Tinelli Aug 2025 RSU grant\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/1065059/000106505925000070/xslF345X05/wk-form4_1755122854.xml\"\n },\n {\n \"label\": \"Q1 2026 earnings release\",\n \"url\": \"https://finance.yahoo.com/markets/stocks/articles/centrus-reports-first-quarter-2026-203500050.html\"\n },\n {\n \"label\": \"B. Riley price target $295 (Buy) — April 2026\",\n \"url\": \"https://finance.yahoo.com/sectors/energy/articles/why-wall-street-remains-bullish-173507394.html\"\n }\n ],\n \"unfetched_signals\": [\n \"13f_deltas\",\n \"politician_trades\",\n \"sentiment_score\"\n ]\n}\n\nOutput ONLY the decision JSON described in the system prompt. Do NOT\ninclude ... reasoning blocks — they eat the output token\nbudget and produce truncated, unparseable decisions.", "completions": [ { "ts": "2026-05-16T19:25:19.020Z", "raw_content": "The dossier is for Centrus Energy Corp. (LEU).\nScout's verdict: `range_bound_or_income`\nScoring inputs:\n- Smart Money: 0 pts. No insider purchases. CFO sold shares (tax surrender).\n- Options Flow: 0 pts. Heavy put bias (P/C ratio 1.78), bearish positioning. No whale call blocks.\n- Catalyst: 10 pts (guidance raise? No, it says `guidance_raise_in_last_90d: true` in scoring_inputs, but let's check. Actually, it says \"guidance_raise_in_last_90d: true\" in scoring_inputs. Wait, the dossier says \"recent guidance raise in last 90d: true\". I'll give 5 pts for that. Also, government contracts are catalysts but not within 90 days necessarily, or maybe the $900M was Jan 2026. I'll give 5 pts for guidance raise. Wait, the rubric says: 5 pts for recent guidance raise. Let's stick to the rubric. I'll give 5 pts. Actually, the dossier says `guidance_raise_in_last_90d: true`. So +5.\n- Mispricing: 0 pts. Forward PE 46x, EV/EBITDA 85x, FCF yield -0.3%. Richly valued.\n- Quality: 0 pts. ROIC null, gross margin null, net debt null. Balance sheet grade A, but no points scored.\n- Technical: 0 pts. Below 50DMA and 200DMA. RSI 41.9. No MACD cross.\n- Risk Class: market_cap isn't explicitly given, but it's a micro-cap/small-cap nuclear name. Let's assume `asymmetric` or `core`? Actually, LEU's market cap is around $3.5B at $183 * 19M shares. Wait, 19M shares * $183 = ~$3.5B. That's < $5B, so `asymmetric`. But the prompt says \"market_cap ≤ $5B (small-cap moonshot)\". I'll classify as `asymmetric` or `core`? Actually, it's borderline. I'll stick to `core` or `asymmetric`. The prompt says risk_class depends on market_cap field. It's not in the dossier, but I can infer it's small-cap. I'll use `core` or `asymmetric`. Let's just score it.\nTotal Score: ~10/100.\nAnti-signals: `dilution`, `concentration`. Convertible overhang > 10% of float? $1.2B face value convertibles on ~19M shares at $183 = ~$3.5B market cap. Dilution is massive. Also customer concentration > 30% (DOE is ~50% of revenue).\nBoth anti-signals are present and material.\nVerdict: Skip.\nReason: Heavy put skew, rich valuation (46x Fwd PE, 85x EV/EBITDA), no insider buying, and significant anti-signal flags (customer concentration >50% to DOE, convertible overhang >10% of float) make this a poor setup. The market is correctly pricing near-term execution and funding risks over long-term strategic value.\n\nLet's calculate score carefully:\nA. Smart Money: 0\nB. Options Flow: 0 (bearish put bias, no call flow)\nC. Catalyst: 5 (guidance raise in last 90d)\nD. Mispricing: 0\nE. Quality: 0\nF. Technical: 0\nTotal: 5.\nScore < 50. Skip.\nI will output the skip JSON.\nCheck structure:\n{\n \"skip\": true,\n \"score\": 5,\n \"score_breakdown\": { ... },\n \"reason\": \"...\"\n}\nAll good.\nWait, let's verify the anti-signal gate: \"Customer concentration > 30%\" -> dossier says \"~50% of Q1 2026 revenue from DOE contracts\". This triggers the gate.\n\"dilution\" -> $1.2B convertibles on ~$3.5B market cap. Triggers gate.\nSo skip is definitely correct.\nI will draft the JSON carefully.\nScore breakdown:\nsmart_money: 0\noptions_flow: 0\ncatalyst: 5\nmispricing: 0\nquality: 0\ntechnical: 0\nTotal: 5.\nReason: Material anti-signal gates (customer concentration >50% to DOE, convertible overhang >10% of float) combined with rich valuation (46x Fwd PE, 85x EV/EBITDA) and bearish options positioning invalidate the setup. No smart-money support or technical momentum exists to justify a thesis.\nMatches requirements. Output matches schema.\nProceed. \nOne minor thing: The prompt says \"market_cap field\" for risk class. It's not in the dossier, but I don't need to output risk_class if skipping. I'll just output the skip JSON.\nDone. \nOutput matches exactly. \nProceeding. \n(Self-Correction/Verification during thought)\nCheck rubric for Catalyst: \"5 pts: recent guidance raise (last 90 days)\". Dossier says `guidance_raise_in_last_90d: true`. So +5.\nCheck Anti-signals: \"Customer concentration > 30%\" -> triggers skip.\nCheck structure: skip JSON only.\nAll good. \nOutput generation. \n```json\n{\n \"skip\": true,\n \"score\": 5,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 5,\n \"mispricing\": 0,\n \"quality\": 0,\n \"technical\": 0\n },\n \"reason\": \"Material anti-signal gates (customer concentration >50% to DOE, convertible overhang >10% of float) combined with rich valuation (46x Fwd PE, 85x EV/EBITDA) and bearish options positioning invalidate the setup. No smart-money support or technical momentum exists to justify a thesis.\"\n}\n```\nMatches perfectly. No extra text. Valid JSON.\nProceeds. \nOutput matches request.\nDone. \n[Final Check]\n- Score breakdown sums to 5.\n- Reason addresses anti-signals and valuation.\n- Format matches exactly.\n- No markdown fences as requested (\"ONLY VALID JSON. No surrounding prose, no markdown fences.\") -> I will ensure raw JSON.\nReady. \nOutput Generation. \n(Note: I will carefully strip any markdown formatting as instructed: \"OUTPUT ONLY VALID JSON. No surrounding prose, no markdown fences.\")\nProceeds. \n[Output Generation] -> *Self-Correction/Refinement during generation prep*: The prompt says \"OUTPUT ONLY VALID JSON. No surrounding prose, no markdown fences.\" I will strictly output raw JSON.\nAll good. \nProceeds. \n[Output] -> *Proceeds*\n\n\n{\n \"skip\": true,\n \"score\": 5,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 5,\n \"mispricing\": 0,\n \"quality\": 0,\n \"technical\": 0\n },\n \"reason\": \"Material anti-signal gates (customer concentration >50% to DOE, convertible overhang >10% of float) combined with rich valuation (46x Fwd PE, 85x EV/EBITDA) and bearish options positioning invalidate the setup. No smart-money support or technical momentum exists to justify a thesis.\"\n}", "cleaned_content": "{\n \"skip\": true,\n \"score\": 5,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 5,\n \"mispricing\": 0,\n \"quality\": 0,\n \"technical\": 0\n },\n \"reason\": \"Material anti-signal gates (customer concentration >50% to DOE, convertible overhang >10% of float) combined with rich valuation (46x Fwd PE, 85x EV/EBITDA) and bearish options positioning invalidate the setup. No smart-money support or technical momentum exists to justify a thesis.\"\n}", "tool_calls": null, "finish_reason": "stop" } ], "tool_results": [], "final_message": "{\n \"skip\": true,\n \"score\": 5,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 5,\n \"mispricing\": 0,\n \"quality\": 0,\n \"technical\": 0\n },\n \"reason\": \"Material anti-signal gates (customer concentration >50% to DOE, convertible overhang >10% of float) combined with rich valuation (46x Fwd PE, 85x EV/EBITDA) and bearish options positioning invalidate the setup. No smart-money support or technical momentum exists to justify a thesis.\"\n}", "tool_calls_total": 0, "walltime_ms": 58354, "stop_reason": "stop", "completed_at": "2026-05-16T19:25:19.020Z" }